News
Durant la pandémie COVID-19, le syndrome inflammatoire multi-systémique a touché 1100 enfants. Depuis cette première description en 2020, des chercheurs du CIRI, des cliniciens des HCL et d’autres collaborateurs internationaux, ont découvert que ce syndrome existait avant le COVID-19 et que d’autres agents infectieux pourraient conduire à ce syndrome inflammatoire grave de l’enfant. Ces résultats sont publiés dans la revue New England Journal of Medicine.
Among the 11 laureates of the PEPR MIE 2023 call for projects (ANRS|Emerging Infectious Diseases), 6 projects involve CIRI teams. Their common aim is to better understand, prevent and control the emergence or re-emergence of infectious diseases.
The PHE3ID/CERP research team has been awarded with one of the first Projets d’Amorçage supported by SHAPE-Med@Lyon
On october 11, the Chaire industrielle REVIDA about respiratory infectious diseases, led by the researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the Université Claude Bernard Lyon 1, the Hospices Civils de Lyon, and bioMérieux, with the support of the Agence nationale de la recherche. It should enable the improvement of the capacity of health systems to face the emerging of new respiratory diseases.
On October 12, 2023, Sidaction donors visited the laboratory of the LP2L team (A. Cimarelli, L. Etienne). Here's a look back at this successful moment of sharing.
Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.
New publication - VIV Team in Nature communication
The planned appointment date will be halfway of 2022-2026, in order to prepare the candidate to take over the management of the Institute starting on 1st January 2027 for a first five-year term. The date of integration into the Institute, ideally mid-2024, should allow a strong involvement in the establishment of the preparation of the CIRI next term project and a transition period with the present Director, François-Loïc Cosset.
Several CIRI teams carried out this work, published in the journal Science Translational Medicine.
Retrouvez Cyrille Mathieu au Festival YGGDRASIL !
— Eurexpo Lyon - Boulevard de l'Europe 69680 ChassieuThe protein that opens doors to the medicine of the future and treatment of COVID-19
Retrouvez son portrait ici
Antibiotic resistance has made certain infections, sometimes common, such as urinary and respiratory infections, impossible to treat, representing a major setback in the medical care of human and animal patients. This resistance has thus become a major health issue, which has led the WHO (World Health Organization) to establish a list of bacteria in which antibiotic resistance is particularly worrying.In a new study published in the journal mBio, we focused on one of these bacteria that are particularly resistant to antibiotics, Acinetobacter baumannii. The latter is responsible for many opportunistic and nosocomial infections. We have determined the mechanisms that allow this bacterium to rapidly acquire resistance genes from neighboring bacteria.
Maladies infectieuses émergentes
The Club Francophone des Cellules Dendritiques (CFCD) is organizing its annual congress in Paris from October 16 to 17, 2021 on “DC-phering mononuclear phagocyte biology in health and disease". Program and information for registration on http://www.cfcd.fr/meeting/registration.php
— Institut Necker Enfants Malades (INEM), ParisModulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein.